Multispectral Bimodal Fluorescence Guided Surgery of High-grade Glioma With Cetuximab-800CW and 5-ALA (5-aminolevulinic Acid)

NCT05929456 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma
High-grade Glioma

Interventions

DRUG: Cetuximab-IRDye800

Sponsor

University Medical Center Groningen